Navigation Links
Accipiter Capital Management Opposes Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc.
Date:2/7/2008

NEW YORK, Feb. 7 /PRNewswire/ -- Accipiter Capital Management, the owner, together with its affiliates, of nearly 10% of the outstanding shares of common stock of VistaCare, Inc. (Nasdaq: VSTA), announced today that it had delivered a letter to VistaCare's Board of Directors expressing its belief that the offer by Odyssey Healthcare, Inc. (Nasdaq: ODSY) to acquire VistaCare for $8.60 per share is wholly inadequate. Accipiter Capital Management and its affiliates do not intend to tender their shares in connection with the acquisition and plan to exercise their appraisal rights to the full extent permissible under law should the tender offer and subsequent merger be consummated.

The text of the letter from Accipiter Capital Management to the Board of Directors of VistaCare follows:

February 6, 2008

BY FACSIMILE AND FEDERAL EXPRESS

The Board of Directors

VistaCare, Inc.

4800 North Scottsdale Road

Suite 5000

Scottsdale, AZ 85251

Ladies and Gentlemen:

Accipiter Capital Management and its affiliates (collectively "Accipiter") currently beneficially own in the aggregate 1,673,350 shares of common stock of VistaCare, Inc. ("VistaCare" or the "Company"), which represents nearly 10% of the Company's total shares outstanding. We believe the offer by Odyssey Healthcare, Inc., through Odyssey Investment, Inc., a wholly owned subsidiary of Odyssey HealthCare Holding Company (collectively, "Odyssey") to
'/>"/>

SOURCE Accipiter Capital Management
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Rural/Metro Board of Directors Meets With Accipiter Capital Management
2. Uroplasty to Present at ROTH Capital Partners 20th Annual OC Growth Stock Conference
3. Treatment capitalizes on unique qualities of radioisotope to prolong lives of brain tumor patients
4. Capital BlueCross CEO Says Meaningful Statewide Competition Must Be Key Criteria in Pennsylvanias Review of Proposed Highmark-IBC Merger
5. Asthma Foundation Announces 2008 Asthma Capitals, Knoxville on Top Again
6. NovaVision to be Featured at 2008 Florida Venture Capital Conference
7. Health Capital Group Warns of Fallout to Hospitals From the Subprime Mortgage Crisis and Urges Hospitals to Immediately Reassess Existing Debt Structures and Capital Financing Plans
8. Huron Capital Caps Strong Year With Five Acquisitions In 4Q07
9. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Security Capital Assurance Ltd.
10. Avista Capital Partners Completes Acquisition of Bristol-Myers Squibb Medical Imaging
11. Mayo Clinic Proceedings provides forum for debate about capital punishment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...arious hospitals affiliated to GSVM medical colleg...' protest against the OBC quota in elite education...ior doctors and students were continuing with the ...mplement 27 per cent quota for OBCs in higher cent...
...0 people in Indonesia are being killed by drugs, a...y by National Narcotics Agency BNN// and the Unive...arge amount of money was being spent on drug traff...the country. 'Some Rupiah12 trillions (local curre...
...t caffeine helps to regulate breathing abnormaliti...pments are less in need for apnea// when infants a... a lower incidence of abnormal lung development a ...abies, who weighed below 1,250 grams, having a ris...
...tate University researchers said, ‘Self-critical a...made when they are grown up in a verbally// abused...abused people are 1.6 times more likely to have sy...ose who had not been verbally abused, a study on 5...
Other Medicine News:
(Date:9/4/2008)... designation for the treatment of Acute Myeloid ... N.J., Sept. 4 /- Celator Pharmaceuti...inistration (FDA) has granted orphan,drug designat...Injection,for the treatment of Acute Myeloid Leuke...duct two randomized Phase 2,studies with CPX-351. ...
(Date:9/4/2008)...aqMan(R) real-time PCR testing for the diagnostic ... Calif., Sept. 4 /- The U.S. Food & D...BAS(R) TaqMan(R) HBV Test,the first assay for qua...S.,The test uses Roche,s real-time PCR technology ... a patient,s blood. Doctors may use viral load,tes...
(Date:9/4/2008)... Obstetrician-Gynecologists States UFE Meets Level... Invasive Interventional,Radiology Treatment Is Sa...ds, FAIRFAX, Va., Sept. 4 /PRNewswire-USNewswire/...ional organization of nearly 4,500 doctors,scient...improving health,care through minimally invasive t...
(Date:9/4/2008)...nroll 750 Women at More Than 100 Sites in the U.S....x Pharmaceuticals, a,privately-held biopharmaceuti...zation of compounds to treat endocrine, metabolic ... it has initiated a second,Phase 3 clinical trial ...estrogen-free oral therapy in development for the ...
Breaking Medicine Technology:Celator Pharmaceuticals Receives Orphan Drug Designation for Anticancer Agent CPX-351 2FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 2Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 3QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3Hologic Chairman and CEO to Open NASDAQ Stock Market on October 2 2007 2518 1Hologic Chairman and CEO to Open NASDAQ Stock Market on October 2 2007 2518 2Hologic Chairman and CEO to Open NASDAQ Stock Market on October 2 2007 2518 3Hologic Chairman and CEO to Open NASDAQ Stock Market on October 2 2007 2518 4Trubion Pharmaceuticals Announces Upcoming Presentations at American College of Rheumatology Annual Scientific Meeting 962 1Trubion Pharmaceuticals Announces Upcoming Presentations at American College of Rheumatology Annual Scientific Meeting 962 2UVA researchers explain cell response to skin damaging UV rays 631 1UVA researchers explain cell response to skin damaging UV rays 631 2Innovator Award to Berkeley Labs Joe Gray for improved breast cancer screening 2510 1Innovator Award to Berkeley Labs Joe Gray for improved breast cancer screening 2510 2Innovator Award to Berkeley Labs Joe Gray for improved breast cancer screening 2510 3Innovator Award to Berkeley Labs Joe Gray for improved breast cancer screening 2510 4
...bility,Significantly Longer than Placebo and had a...h Placebo , MARIETTA, Ga. and COLLEGEVILLE, Pa., M...Pharmaceuticals, a division of Wyeth,(NYSE:WYE), a...n,bifeprunox, an investigational treatment for adu... the 2007 annual meeting of,the American Psychiatr...
...EL XR--, WILMINGTON, Del., May 22, 2007 /PRNewswir...wo analyses from a large-scale,study that investig...umarate) Extended-Release Tablets, a once-daily me... patients, were presented today,at the annual meet... These analyses from the clinical trial data for S...
Other Medicine Technology:New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 2New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 3New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 4New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 5New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 2New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 3New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 4New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 5New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 6New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 7New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 8New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 9
Clearview C. Diff A is a one-step test for the direct qualitative detection of Clostridium difficile toxin A from fecal samples.
ThyroTest TSH is a rapid, qualitative test for hypothyroidism screening in adults.
...est is one of the easiest tests to run on the mark...s with no hands-on time. Critical care instruction...aving the pediatrician's office and valuable infor... to help control the spread of RSV infections. Now...
The BinaxNOW Influenza A & B Test simplifies rapid influenza testing. The easiest flu test on the market just got easier with accurate differentiation between influenza A and influenza B using one si
Medicine Products: